The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
April 28th 2025
From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ground.
Sinonasal CT Scores May Predict Prognostic Features of Chronic Rhinosinusitis With Nasal Polyps
February 2nd 2022Sinonasal CT scores were associated with several prognostic features in the disease course of chronic rhinosinusitis with nasal polyps, including blood eosinophil counts and risk of relapse after endoscopic sinus surgery.
Read More
Overall Effectiveness of Atrial Shunt for HFpEF Remains Questionable
February 1st 2022There is a persistent lack of effective treatments for heart failure with preserved ejection fraction (HFpEF), so in this study, investigators examined the impact of an atrial shunt among patients with this disease subtype.
Read More
Risdiplam May Be Superior for Certain SMA Type, According to Indirect Comparison
January 30th 2022Researchers compiled data from studies of oral Evrysdi (risdiplam), Spinraza (nusinersen), and Zolgensma (onasemnogene abeparvovec), finding evidence that risdiplam may be a favorable alternative to nusinersen for type 1 SMA.
Read More
Presence of NAFLD Cirrhosis Impacts Best Response to Immunotherapy in Patients With HCC
January 29th 2022Disease progression was more likely to be the best response to immunotherapy for patients with hepatocellular carcinoma (HCC) and cirrhosis due to nonalcoholic fatty liver disease (NAFLD).
Read More
Report Describes Consequences of Airway Remodeling in Pediatric Nonresponders to Omalizumab
January 28th 2022A recent case report described 3 pediatric patients with severe asthma whose disease was not managed according to care guidelines and who did not respond to the biologic by the time they began therapy.
Read More
LV Changes, CABG Contribute to Higher Mortality Risk From Heart Failure
January 28th 2022In this new study from China, the link between left ventricular (LV) structural changes and mortality following coronary artery bypass grafting (CABG) was investigated among a patient cohort with heart failure with reduce ejection fraction.
Read More
Incyte Withdraws FDA Submission for Parsaclisib for FL, MZL, MCL
January 27th 2022Incyte has become the latest company to pull an FDA filing following Gilead and Secura Bio, which both voluntarily withdrew therapies that had been granted accelerated approval but hadn’t completed confirmatory studies for full approval.
Read More
Point-of-Care Testing Has Potential to Expand the Reach of NGS for CRC
January 27th 2022This 9-month investigation looked into the potential for next-generation sequencing (NGS) at the point of care to increase turnaround time for biomarker testing results in advanced colorectal cancer (CRC).
Read More
Multidisciplinary Care Emphasized for Pregnant Women With SMA
January 27th 2022According to researchers, this case of a patient with spinal muscular atrophy (SMA) from Indonesia was the first to use a collaborative, multidisciplinary approach that involved obstetric, neurology, pediatric, and anesthesiology departments at a hospital.
Read More
MRD Continues to Reliably Predict Disease Progression in CRC
January 24th 2022In this poster presented at the 2022 ASCO Gastrointestinal Cancers Symposium, minimal residual disease (MRD) status as detected by postsurgery plasma cell-free DNA continued its strong track record of being a reliable predictor of disease progression in colorectal cancer (CRC).
Read More
Dr David R. Stukus on Eosinophilic Esophagitis Guidelines and the Pattern of Disease
January 24th 2022David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology, discusses guidelines for eosinophilic esophagitis, as well as some disease patterns that may occur.
Watch
Genomic Profiling Uncovers Mutations More Enriched in Early-Onset Colorectal Cancer
January 24th 2022Findings presented at the 2022 ASCO Gastrointestinal Cancers Symposium showed no significant differences in tissue and plasma genomic profiles of patients with early-onset and late-onset colorectal cancer, but a greater enrichment of the BRCA1 and PTEN mutations were noted in the tissue of those with early-onset disease.
Read More
Large, Retrospective Study Offers Insight Into AGEP Disease Course, Complications
January 22nd 2022Among the most notable findings were that acute generalized exanthematous pustulosis is typically triggered by antimicrobial agents and may be associated with complications of the liver or kidney for some patients.
Read More